Pune, India, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Neurorehabilitation Devices Market Overview:
According to Market Redsearch Future (MRFR), the Neurorehabilitation Devices Market was valued USD 793.0 Million in 2018 and is estimated to cross USD 2,274.1 Million till 2025, with a double digit CAGR of 16.4% in the forecast period.
The neurorehabilitation devices entail the use of technology in the field of physiotherapy as most neurological rehabilitation devices target to enable learning or relearning of motor skills regardless of the cause of impairment.
The increased occurrence of neurological illnesses that impede motor movement or other voluntary actions is estimated to gain traction in the future with overwhelming evidencediscovery of genetic predisposition and environmental stress factors that trigger these conditions.The increased need for neurorehabilitation devices due to these rising number of neurological disorder cases, the emergence of robotic rehabilitation, a surge in the geriatric population, and the effectiveness of the gaming systems in neurorehabilitation are likely to benefit the neurorehabilitation devices market.Stringentsupervisory policies and growingskilled professionals' necessities are anticipated to burden neurorehabilitation devices' market growth during the forecast period.
Neurorehabilitation Devices Demand To Sharply Rise
The market is projected to see profitable growth due to neurological disorder cases such as Parkinson's, epilepsy, multiple sclerosis, Alzheimer's, stroke, and essential tremors being detected increasingly.COVID-induced lockdowns impacted many patients with neurological ailments as they had no access to their therapists and hence could not undertake their sessions, leading to loss of progress. This factor has led researchers at the VTC Smart Rehab Lab toadvancean inexpensive breakthroughtechnology. It approaches to link stroke survivors to physical therapy at home via tele-rehabilitation. The procedure will include a fused knowledge basis of machine learning and human interfacing to evaluate patient performance in training and daily activities at home while simultaneously delivering feedback to the patient and reviewing progress to the remote therapist. This major innovation can be magnified to various therapy needs leading to the lab being bestowed with USD 1.1 million by the National Science Foundation to keep onadvancing its Semi-Automated Rehabilitation At Home (SARAH) project.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/2210
Researchers are also engaged in assessing the efficiency and the suitability of implementing commercial games for neurorehabilitation leading to the wearable devices segment's fastest-growing segment with a 16.8% CAGR in ...
Full story available on Benzinga.com